BofA/Merrill Lynch Downgrades Mindray Medical (MR) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Mindray Medical International (MR) Tops Q1 EPS by 2c
May 5, 2014 5:00 PM EDTMindray Medical International (NYSE: MR) reported Q1 EPS of $0.39, $0.02 better than the analyst estimate of $0.37. Revenue for the quarter came in at $264.8 million versus the consensus estimate of $292.5 million.
For earnings history and earnings-related data on Mindray Medical International (MR) click here.
... More